Trump's Cabinet Nominees Face Grilling Over Epstein Files, Election Claims, and Science

A Day of High-Stakes Hearings on Capitol Hill

On Wednesday, July 15, the Senate put three of President Trump's key nominees through the wringer in back-to-back confirmation hearings that touched on some of the most contentious issues in American public life — the Jeffrey Epstein files, the legitimacy of the 2020 election, and the independence of the nation's top public health agency. The nominees: acting Attorney General Todd Blanche, intelligence director nominee Jay Clayton, and CDC director nominee Dr. Erica Schwartz. Each faced a Senate chamber where partisan lines were drawn sharply, and where a single Republican defection could spell disaster.

Blanche has led the Justice Department since April, when Trump pushed out his first attorney general, Pam Bondi, and elevated Blanche to the top job on an acting basis. Trump's former personal lawyer, Blanche appeared for what many expected to be a contentious hearing amid questions about his handling of the Epstein files, the targeting of Trump's political foes, and the broader politicization of justice.

Blanche Under Fire: Epstein, the IRS Deal, and a Telling Slip

Senators pressed Blanche on his handling of the Jeffrey Epstein files, particularly after his predecessor Pam Bondi told lawmakers that Blanche was the department's point person on the release of documents from the sex trafficking case. The staggered release, mandated by an act of Congress, was beset by problems, including redaction errors that left exposed nude photos showing the faces of potential victims, with some names, email addresses, and other identifying information either unredacted or not fully obscured.

The $1.776 billion Anti-Weaponization Fund created a particularly rocky moment for Blanche. He initially defended it during congressional appearances only to reveal later that it was being scrapped — even while resisting calls to give those reassurances in writing. Sen. Thom Tillis of North Carolina said he was leaning yes on advancing Blanche's nomination, but first needed to see President Trump endorse a legislative move to kill the proposed fund once and for all. Then came an unintentional moment that encapsulated Democratic concerns: when asked by Sen. John Kennedy whether he and Trump were friends, Blanche responded, "I'm his lawyer — was his lawyer. And now I'm the deputy attorney general." Before his DOJ roles, Blanche had been Trump's personal attorney, representing the president in multiple criminal cases, including the federal classified documents and election obstruction cases. Blanche's confirmation is far from assured, as he faces an even narrower Senate margin following Sen. Lindsey Graham's sudden death, which left the Judiciary Committee Republicans with just one vote to lose.

Clayton Dodges the 2020 Question, Schwartz Pledges to Follow the Science

Jay Clayton, Trump's pick to head the nation's intelligence agencies, emphasized his experience in government and national security as he testified before the Senate Intelligence Committee, working to distinguish himself from interim director Bill Pulte — a former housing official with no known intelligence background. Democratic senators questioned Clayton on Trump's allegations about the validity of the 2020 election and subpoenas on journalists. The nominee refused to say directly that Joe Biden won the 2020 election, saying instead that Biden was "certified" as president and that he is "not an election denier." Clayton's confirmation carries added urgency, as it is key to the extension of certain U.S. spy powers involving a foreign surveillance program that expired more than a month ago. Democrats have said they will not vote for Section 702 of the Foreign Intelligence Surveillance Act as long as Pulte remains director.

Dr. Erica Schwartz is Trump's third nominee to lead the nation's beleaguered public health agency, which has not had a permanent director for most of Trump's second term in office. In her opening statement, Schwartz declared, "If confirmed, my first priority will be restoring trust in public health institutions through radical transparency and unwavering scientific integrity. I will never betray the science." Sen. Bill Cassidy pressed Schwartz on her willingness to stand up to potential political interference by Health Secretary Robert F. Kennedy Jr. Schwartz said if confirmed, she would serve. "I will continue to live and lead by my integrity," she said. "If I'm confirmed as the CDC director, the nation's health and well-being will take primacy and I will never compromise on that." The HELP committee will now decide whether to advance Schwartz's nomination for a full Senate vote. She is expected to clear the Senate confirmation process.

What Comes Next

The Senate Judiciary Committee's nomination hearing for Blanche reconvened Thursday, July 16, for an executive business meeting, followed by testimony from a panel of outside witnesses. Among the witnesses: former Attorney General John Ashcroft; Jon Adler of the Federal Law Enforcement Officers Association Foundation; and Dani Bensky, a survivor of Jeffrey Epstein. The votes of a handful of